GMC concerns specific to psychiatric practice, boundary violations in therapeutic relationships, consent and capacity in psychiatric patients, confidentiality in mental health, and prescribing concerns
Psychiatric practice presents unique regulatory challenges — and a distinctive pattern of GMC fitness to practise concerns. The therapeutic relationship in psychiatry carries inherent boundary risks unlike those in most other specialties. Consent and capacity issues are more complex where patients may have fluctuating or impaired decision-making ability. Confidentiality obligations intersect with third-party risk in specific ways. Understanding how the GMC approaches these issues is essential for any psychiatrist facing investigation.
Psychiatrists face GMC fitness to practise concerns that arise partly from the same sources as other doctors — clinical competence, consent, prescribing — and partly from challenges that are specific to psychiatric practice.
The most distinctive are professional boundary concerns in therapeutic relationships and the specific consent and capacity challenges that arise when treating patients with psychiatric conditions.
The therapeutic relationship in psychiatry is inherently intimate. Patients share highly personal material.
The work involves sustained, close professional contact over extended periods. These features make psychiatric practice particularly vulnerable to boundary erosion — and make the GMC's assessment of boundary concerns in psychiatric cases particularly rigorous.
The broader framework for professional boundaries across all healthcare settings is set out in the guide to professional boundaries in healthcare. This guide addresses the specific features of boundary and consent concerns in psychiatric practice.
CPD Certified — Online — Immediate Access
Professional boundary violations in psychiatric practice occur on a spectrum — from subtle boundary crossings (excessive self-disclosure, extending sessions, extra-therapeutic contact) through to serious violations (sexual relationships with patients, emotional exploitation, dual role conflicts).
The GMC treats boundary violations in therapeutic relationships with particular seriousness because of the power differential inherent in psychiatric treatment, the vulnerability of many psychiatric patients, and the specific harm that boundary violations cause in a therapeutic context —
including harm to the patient's mental health itself, harm to their ability to trust future therapeutic relationships, and harm to public confidence in psychiatric services.
Consent to a romantic or sexual relationship is not a defence to a boundary violation in psychiatry. The GMC's position —
consistent with all major regulatory bodies — is that a sexual relationship with a current psychiatric patient is never acceptable, regardless of perceived consent. The therapeutic relationship creates a power dynamic that makes genuine consent impossible.
For former patients, the position is more nuanced. The GMC considers the nature and duration of the therapeutic relationship, the vulnerability of the patient, and the time elapsed since treatment ended. Psychiatric treatment relationships are generally considered to create longer-lasting boundary obligations than other medical relationships.
Consent and capacity in psychiatric settings involve a specific legal framework — the Mental Capacity Act 2005 and, for compulsory detention and treatment, the Mental Health Act 1983. A psychiatrist whose GMC concern involves consent or capacity must demonstrate understanding of both frameworks.
Common consent and capacity concerns in psychiatric GMC cases include: treating a patient who lacked capacity without a proper best interests assessment; failing to document capacity assessments adequately; applying the wrong legal framework (using MHA powers when MCA consent was required, or vice
versa); and failing to explore and respect the wishes of a patient who lacks capacity in their best interests decision.
Capacity is decision-specific and time-specific — a patient may have capacity to consent to some decisions but not others, and capacity may fluctuate. The GMC's assessment focuses on whether the psychiatrist's approach to capacity at each decision point met the legal and professional standard.
The informed consent framework provides the foundational context, with MCA and MHA-specific requirements overlaying it for psychiatric practice.
Psychiatric practice creates specific confidentiality challenges. Mental health information is among the most sensitive personal data. Patients may share information that relates to third-party risk —
including potential harm to others. The balance between maintaining confidentiality and disclosing to protect third parties is a recurring ethical challenge in psychiatric practice.
Common confidentiality concerns in psychiatric GMC cases include: inappropriate disclosure of patient information to family members without consent; disclosure to employers or other third parties without a valid legal basis; failure to manage risk disclosures in accordance with the relevant
guidance; and breaches arising from inadequate information security in mental health records.
Where a psychiatrist has disclosed information to protect a third party from serious harm, the disclosure may be legally justified —
but it must have been made on the basis of a properly documented risk assessment, after consideration of whether consent could be obtained, and in accordance with the GMC's confidentiality guidance. Post-hoc justification is not sufficient.
Prescribing concerns in psychiatric GMC cases commonly involve antipsychotic prescribing outside licensed parameters, inadequate monitoring of high-risk medications (clozapine, lithium, mood stabilisers), prescribing controlled drugs to patients with substance misuse histories, and
physical health monitoring failures in patients on long-term psychiatric medication.
The GMC's assessment of psychiatric prescribing focuses on whether the prescribing decision was clinically justified, whether the patient was adequately monitored, and whether the prescribing met the standards of a competent psychiatrist in the relevant context.
RCPsych prescribing guidelines and NICE guidance provide the specialist standard against which prescribing is assessed.
Remediation in psychiatric GMC cases must address the specific concern raised with specialty-appropriate evidence. For boundary violation cases — the most common and most serious psychiatric GMC concern —
remediation evidence must demonstrate genuine understanding of the specific dynamics of therapeutic relationships, the power imbalance inherent in psychiatric treatment, and the specific harm that boundary violations cause to vulnerable patients.
Professional ethics and boundary-specific CPD, combined with a reflective statement that engages specifically with the psychiatric therapeutic context, provides a more credible remediation basis than generic professional development.
The guide to demonstrating remediation to your regulator provides the framework within which psychiatric-specific evidence should be situated.
UK-registered doctors can access professional ethics training through Healthcare Ethics Courses.
Doctors with connections to Ireland can consult ethics training for doctors in Ireland.
Those with connections to Canada can review professional development for Canadian doctors.
10 CPD-certified courses for £500. Professional ethics, professional boundaries, and consent standards — the foundational CPD that complements psychiatric specialty-specific remediation.
Bulk Buy 10 Courses →Professional boundary violations in therapeutic relationships, consent and capacity concerns in psychiatric patients, confidentiality issues in mental health settings, and prescribing concerns — particularly around high-risk medications and monitoring. Boundary violations are the most distinctive and frequently serious category.
Yes. The GMC considers the nature and duration of the therapeutic relationship, the vulnerability of the patient, and the time elapsed since treatment ended. Psychiatric treatment relationships create longer-lasting boundary obligations than most other medical relationships — the therapeutic transference created in psychiatric treatment does not end when the formal relationship concludes.
No. The GMC's position is that a sexual or romantic relationship with a current psychiatric patient is never acceptable, regardless of perceived consent. The power differential inherent in psychiatric treatment makes genuine consent impossible in this context.
The Mental Capacity Act 2005 governs capacity assessment and best interests decisions for patients who lack capacity. The Mental Health Act 1983 governs compulsory detention and treatment for patients with mental disorder who meet the statutory criteria. GMC case examiners assess whether the psychiatrist applied the correct legal framework at each decision point.
Yes — where the risk of serious harm to an identified third party is sufficiently serious and cannot be managed any other way. The disclosure must be based on a properly documented risk assessment, and alternatives to disclosure must have been considered. Post-hoc justification is not sufficient.
RCPsych prescribing guidelines and NICE guidance provide the specialist standard. The GMC assesses whether prescribing decisions were clinically justified, whether patients were adequately monitored, and whether high-risk medication monitoring met the standard of a competent psychiatrist in the relevant context.
Yes. Inadequate clozapine monitoring — particularly failure to check mandatory haematological parameters, failure to register with the clozapine monitoring service, or failure to respond appropriately to abnormal results — is a specific and serious prescribing concern in psychiatric GMC cases.
Against the standard of Good Medical Practice and the specific guidance on maintaining professional boundaries in therapeutic relationships. The GMC considers the inherent vulnerability of psychiatric patients, the power dynamics of the therapeutic relationship, and the specific harm caused by boundary violations in a mental health treatment context.
CPD specifically addressing professional boundaries in therapeutic relationships, the dynamics of transference and countertransference, and the specific regulatory standards applicable to psychiatric practice. General professional ethics CPD should complement specialty-specific boundary training.
Usually yes, unless an interim order has been imposed. Where the concern involves ongoing patient contact risks — particularly for sexual boundary violations — an interim order may be applied for urgently. The doctor should discuss their practice arrangements with their legal team and MDO immediately.
The GMC may appoint a Royal College of Psychiatrists fellow as an independent expert in psychiatric cases. The RCPsych also provides pastoral support and guidance for psychiatrists in difficulty through its professional support unit.
Through specific professional development addressing therapeutic boundary dynamics in psychiatric practice, a reflective statement that demonstrates genuine understanding of the power imbalance involved and the specific harm caused, structural changes to practice arrangements, and — where appropriate — supervisor confirmation that professional relationships are now managed appropriately.
No — the duty of candour applies to all registered doctors equally. However, its application in psychiatric settings can be complex where the patient lacks capacity or where disclosure of the adverse event itself may have a mental health impact. These complexities require careful clinical judgment and legal advice.
This guide is for educational purposes only and does not constitute legal advice. If you are facing GMC fitness to practise proceedings, seek independent legal advice from a solicitor experienced in GMC regulatory proceedings.
